250 related articles for article (PubMed ID: 12847108)
1. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles.
Déléris P; Bacqueville D; Gayral S; Carrez L; Salles JP; Perret B; Breton-Douillon M
J Biol Chem; 2003 Oct; 278(40):38884-91. PubMed ID: 12847108
[TBL] [Abstract][Full Text] [Related]
2. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
3. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.
Taylor V; Wong M; Brandts C; Reilly L; Dean NM; Cowsert LM; Moodie S; Stokoe D
Mol Cell Biol; 2000 Sep; 20(18):6860-71. PubMed ID: 10958682
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
Maehama T; Dixon JE
J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
[TBL] [Abstract][Full Text] [Related]
5. PTEN and Other PtdIns(3,4,5)P
Csolle MP; Ooms LM; Papa A; Mitchell CA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide phosphatases: just as important as the kinases.
Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
[TBL] [Abstract][Full Text] [Related]
7. Evidence of SHIP2 Ser132 phosphorylation, its nuclear localization and stability.
Elong Edimo W; Derua R; Janssens V; Nakamura T; Vanderwinden JM; Waelkens E; Erneux C
Biochem J; 2011 Nov; 439(3):391-401. PubMed ID: 21770892
[TBL] [Abstract][Full Text] [Related]
8. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
9. Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression.
Lindsay Y; McCoull D; Davidson L; Leslie NR; Fairservice A; Gray A; Lucocq J; Downes CP
J Cell Sci; 2006 Dec; 119(Pt 24):5160-8. PubMed ID: 17158918
[TBL] [Abstract][Full Text] [Related]
10. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
Eramo MJ; Mitchell CA
Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
[TBL] [Abstract][Full Text] [Related]
11. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
12. An SH2 domain-containing 5' inositolphosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament rearrangement.
Vollenweider P; Clodi M; Martin SS; Imamura T; Kavanaugh WM; Olefsky JM
Mol Cell Biol; 1999 Feb; 19(2):1081-91. PubMed ID: 9891043
[TBL] [Abstract][Full Text] [Related]
13. The INPP4B paradox: Like PTEN, but different.
Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of lentiviral vector-mediated SHIP gene transfection on proliferation of leukemia K562 cells and PI3K/Akt pathway regulation].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L
Ai Zheng; 2009 Apr; 28(4):366-72. PubMed ID: 19622295
[TBL] [Abstract][Full Text] [Related]
15. PTEN M-CBR3, a versatile and selective regulator of inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5). Evidence for Ins(1,3,4,5,6)P5 as a proliferative signal.
Orchiston EA; Bennett D; Leslie NR; Clarke RG; Winward L; Downes CP; Safrany ST
J Biol Chem; 2004 Jan; 279(2):1116-22. PubMed ID: 14561749
[TBL] [Abstract][Full Text] [Related]
16. SHIP-2 forms a tetrameric complex with filamin, actin, and GPIb-IX-V: localization of SHIP-2 to the activated platelet actin cytoskeleton.
Dyson JM; Munday AD; Kong AM; Huysmans RD; Matzaris M; Layton MJ; Nandurkar HH; Berndt MC; Mitchell CA
Blood; 2003 Aug; 102(3):940-8. PubMed ID: 12676785
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
18. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
[TBL] [Abstract][Full Text] [Related]
19. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
20. The diversity and possible functions of the inositol polyphosphate 5-phosphatases.
Erneux C; Govaerts C; Communi D; Pesesse X
Biochim Biophys Acta; 1998 Dec; 1436(1-2):185-99. PubMed ID: 9838104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]